Zobrazeno 1 - 10
of 24
pro vyhledávání: '"D. N. Kiortsis"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G A, Christou, D N, Kiortsis
Publikováno v:
Obesity reviews : an official journal of the International Association for the Study of Obesity. 18(3)
Orthostatic intolerance (OI) is frequently the mechanism underlying the occurrence of noncardiac syncope (NCS) and is associated with substantial risk for injury. Body weight status appears to be a modifier of orthostatic responses and possibly influ
Autor:
D. N. Kiortsis, F. D. Christopoulou
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 36:10-18
Summary What is known and objective: Rimonabant, a cannabinoid receptor blocker, has recently been used in clinical practice for weight loss and weight maintenance. Our aim was to review the results of trials of the drug in relation to weight loss an
Publikováno v:
Metabolic Syndrome and Related Disorders. 8:173-178
Background: It is known that weight loss is beneficial for obese and overweight subjects with metabolic syndrome. Very few data exist, however, about whether the presence of metabolic syndrome and insulin resistance (IR) influence the response of the
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Journal of Pediatrics. 158:446-450
The purpose of the study was to examine the effects of weight loss on resting metabolic rate (RMR) and on serum T3 levels in obese children and to investigate whether RMR changes are related to T3 changes. Sixty-four healthy, overweight, children (ag
Autor:
G A, Christou, D N, Kiortsis
Publikováno v:
Obesity reviews : an official journal of the International Association for the Study of Obesity. 14(12)
Adiponectin is secreted by the adipose tissue and it has been shown to be down-regulated in states of insulin resistance and in cardiovascular disease. It has also been found to be correlated with various parameters of lipoprotein metabolism, and in
Autor:
F D, Christopoulou, D N, Kiortsis
Publikováno v:
Journal of clinical pharmacy and therapeutics. 36(1)
Rimonabant, a cannabinoid receptor blocker, has recently been used in clinical practice for weight loss and weight maintenance. Our aim was to review the results of trials of the drug in relation to weight loss and maintenance, and its impact on card
Publikováno v:
Obesity reviews : an official journal of the International Association for the Study of Obesity. 12(5)
Obesity is a pathological condition aggregating a substantial number of proatherogenic factors, such as insulin resistance, type 2 diabetes mellitus, dyslipidaemia and hypertension. In addition to these classic cardiometabolic risk factors, atheroscl
Publikováno v:
Clinical and experimental rheumatology. 29(4)
In the last two decades we have witnessed a boost in scientific interest and knowledge of adipose tissue biology to such an extent that it was promoted to an active endocrine organ. Adipose tissue is not just related to body weight and appetite regul